InsiderTrades

Form 4 for RLMD RELMADA THERAPEUTICS, INC.

Accepted 2024-01-31 00:00:00 ET · period of report 2024-01-29 · accession 0001213900-24-008559 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-01-31 2024-01-29+ RLMD Shenouda Maged CFO P - Purchase $3.85 +32.7K 28.0K New +$125.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-31 P A 6,875 $4.06 34,903 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F4) Purchase prices range from $3.95 to $4.18 per share, inclusive.
2 Common Common Stock 2024-01-29 P A 10,800 $3.65 13,028 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F2) Purchase prices range from $3.57 to $3.745 per share, inclusive.
3 Common Common Stock 2024-01-30 P A 15,000 $3.89 28,028 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F3) Purchase prices range from $3.82 to $3.90 per share, inclusive.